A continuous tri-phase transition effect for HIFU-mediated intravenous drug delivery

Biomaterials

Volumn 35, Issue 22, 2014, Pages 5875-5885

  Zhang, Kun ^a   Chen, Hangrong ^a   Li, Faqi ^b   Wang, Qi ^b   Zheng, Shuguang ^c   Xu, Huixiong ^c   Ma, Ming ^a   Jia, Xiaoqing ^a   Chen, Yu ^a   Mou, Juan ^a   Wang, Xia ^a   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Continuous ultrasound imaging; HIFU mediated drug delivery; Repeated HIFU treatment; Tri phase transition

Indexed keywords

BIOHAZARDS; CHEMOTHERAPY; DRUG DELIVERY; TUMORS; ULTRASONIC IMAGING;

DRUG RELEASE PROPERTIES; HYDROPHOBIC AND HYDROPHILIC; INTRAVENOUS INJECTIONS; MULTIPLE-MODELING; REPEATED HIFU TREATMENT; TEMPERATURE-RESPONSIVE; TRI-PHASE TRANSITION; ULTRASOUND IMAGING;

LOADING;

HOLLOW MESOPOROUS SILICA NANOCAPSULE; NANOCAPSULE; SILICON DIOXIDE; UNCLASSIFIED DRUG; COLORING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSAFETY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FEMALE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN CELL; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; ANIMAL; BOVINAE; CELL SURVIVAL; HELA CELL LINE; NEOPLASMS; PROCEDURES; RABBIT;

ANIMALS; CATTLE; CELL SURVIVAL; COLORING AGENTS; DRUG DELIVERY SYSTEMS; HELA CELLS; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; NEOPLASMS; PHASE TRANSITION; RABBITS;

EID: 84899952809     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.043     Document Type: Article

References (31)

1. Hill C.R., ter Haar G.R. High intensity focused ultrasound-potential for cancer treatment. Br J Radiol 1995, 68:1296-1303.
2. Kennedy J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005, 5:321-327.
3. Illing R.O., Kennedy J.E., Wu F., Haar G.R.T., Protheroe A.S., Friend P.J., et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 2005, 93:890-895.
4. Kennedy J.E., ter Haar G.R., Cranston DBr High intensity focused ultrasound: surgery of the future?. Br J Radiol 2003, 76:590-599.
5. Kennedy J.E., Middleton M.R., Cranston D. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics 2004, 42:931-935.
6. Haar G.R., Sc D. High intensity focused ultrasound for the treatment of tumors. Echocardiography 2001, 18:317-322.
7. Wu F., Wang Z.-b., Chen W.-z., Zhu H., Al F. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 2004, 11:1061-1069.
8. W-s Chen, Lafon C., Matula T.J., Vaezy S., Crum L.A. Mechanisms of lesion formation in high intensity focused ultrasound therapy. Acoust Res Lett Online 2003, 4:41-46.
9. Zderic V., Brayman A.A., Sharar S.R., Crum L.A., Vaezy S. Microbubble-enhanced hemorrhage control using high intensity focused ultrasound. Ultrasonics 2006, 45:113-120.
10. Niu D., Wang X., Li Y., Zheng Y., Li F., Chen H., et al. Facile synthesis of magnetite/perfluorocarbon co-loaded organic/inorganic hybrid vesicles for dual-modality ultrasound/magnetic resonance imaging and imaging-guided high-intensity focused ultrasound ablation. Adv Mater 2013, 25:2686-2692.
11. Wang X., Chen H., Zheng Y., Ma M., Chen Y., Zhang K., et al. Au-nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation. Biomaterials 2013, 34:2057-2068.
12. Wang X., Chen H., Chen Y., Ma M., Zhang K., Li F., et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater 2012, 24:785-791.
13. Sun Y., Zheng Y., Ran H., Zhou Y., Shen H., Chen Y., et al. Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials 2012, 33:5854-5864.
14. Chen Y., Chen H., Sun Y., Zheng Y., Zeng D., Li F., et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew Chem Int Ed 2011, 50:12505-12509.
15. Prentice P., Cuschieri A., Dholakia K., Prausnitz M., Campbell P. Membrane disruption by optically controlled microbubble cavitation. Nat Phys 2005, 1:107-110.
16. Fu W.-M., Yang R.-S., Liou H.-C., Kang K.-H., Win L.-I. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med Biol 2007, 33:1421-1427.
17. Unger E.C., Porter T., Culp W., Labell R., Matsunaga T., Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 2004, 56:1291-1314.
18. Wang C.-h., Kang S.-t., Lee Y.-h., Luo Y.-l., Huang Y.-f., Yeh C.-k. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012, 33:1939-1948.
19. Wu J., Nyborg W.L. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 2008, 60:1103-1116.
20. Schutt E.G., Klein D.H., Mattrey R.M., Riess J.G. Ultrasound contrast agents injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed 2003, 42:3218-3223.
21. Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., Kaul S. Direct invivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998, 98:290-293.
22. Moon G.D., S-w Choi, Cai X., Li W., Cho E.C., Jeong U., et al. Anew theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release. JAm Chem Soc 2011, 133:4762-4765.
23. Wang Y., Gao S., Ye W.-H., Yoon H.-S., Yang Y.-y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 2006, 5:791-796.
24. Hu S.-h., Chen S.-y., Gao X. Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release. ACS Nano 2012, 6:2558-2565.
25. Dergunov S.A., Pinkhassik E. Synergistic co-entrapment and triggered release in hollow nanocapsules with uniform nanopores. JAm Chem Soc 2011, 133:19656-19659.
26. Zhang K., Chen H., Zheng Y., Chen Y., Ma M., Wang X., et al. Afacile in situ hydrophobic layer-protected selective etching strategy for the synchronous Synthesis/modification of hollow or rattle-type silica nanoconstructs. JMater Chem 2012, 22:12553-12561.
27. Chen Y., Chen H., Guo L., He Q., Chen F., Zhou J., et al. Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 2010, 4:529-539.
28. Rinking P.E.J.A.F., Ouakaz A.Y.B., Irkhorn J.O.K., Ate F.O.J.T.E.N.C. Ultrasound contrast imaging: current and new potential methods. Ultrasound Med Biol 2000, 26:965-975.
29. Elson T.H.R.N., Retorius D.O.H.P. Three-dimensional ultrasound imaging. Ultrasound Med Biol 1998, 24:1243-1270.
30. Bazan-peregrino M., Arvanitis C.D., Rifai B., Seymour L.W., Coussios C.-c. Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an invitro model. JControl Release 2011, 157:235-242.
31. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. JControl Release 2000, 65:271-284.